BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29

• 

  Earnings

  Moderna’s Bancel Nay on M&A, Yay on R&D Partnerships

  It’s not often that a CEO outright dismisses M&A prospects, but Moderna CEO Stéphane Bancel says the mRNA biotech has enough programs on its hands.

  August 1, 2025

   · 

  4 min read

   · 

  Annalee Armstrong
• Press Releases

  Viatris Announces Five Data Presentations on Novel Fast-Acting Meloxicam (MR-107A-02) at PAINWeek 2025 Conference

  August 1, 2025

   · 

  5 min read
• 

  Patents

  Moderna Wins UK Patent Battle Against Pfizer and BioNTech

  A U.K. Court of Appeals ruling confirms the validity of a patent covering modifications of mRNA used in Moderna’s vaccines.

  August 1, 2025

   · 

  2 min read

   · 

  Dan Samorodnitsky
• 

  Earnings

  Regulatory Roadblocks Blemish Regeneron’s Otherwise Strong Q2

  Delays in the decision dates for high-dose Eylea are linked to issues at a Catalent-owned facility. Once these are resolved, Regeneron expects “to receive favorable action” on these applications, CEO Leonard Schleifer told investors.

  August 1, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  Nanox to Report Second Quarter 2025 Financial Results on August 12, 2025

  August 1, 2025

   · 

  1 min read
• Press Releases

  Exicure Completes the Last Patient, Last Visit in Phase 2 Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant

  August 1, 2025

   · 

  2 min read